Literature DB >> 2501253

Preventive and antiproliferative effects of tumor necrosis factor against experimental hepatic metastases of mouse colon-26 tumor.

Y Nishiyama1, S Fuchimoto, K Orita.   

Abstract

This investigation was undertaken in order to assess both the preventive and antiproliferative effects of tumor necrosis factor (TNF) in a hepatic metastasis model, by means of inoculation of mouse colon-26 tumor cells into the portal vein via the superior mesenteric vein in male CDF1 mice, aged 5 weeks. Continuous 10-day administration of natural human TNF-alpha (nHuTNF-alpha) following the tumor cell inoculation caused no reduction but rather an increase in the number of hepatic metastases. However, pretreatment with this preparation daily for 10 days before the inoculation caused a remarkable decrease in the number of hepatic metastases. This prophylactic effect was reversed by the intravenous administration of anti-asialo GM1 antibody 24 h before the inoculation. The result of immunoperoxidase staining of liver specimens suggested that organ-associated natural killer cells might play a role in the metastatic inhibition. An apparent antiproliferative effect on metastatic liver tumors was also recognized following injection of nHuTNF-alpha from the 10th day after the inoculation. Thus, TNF appears to have important effects upon the host immune system, acting against liver metastases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501253      PMCID: PMC5917740          DOI: 10.1111/j.1349-7006.1989.tb02321.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


natural human tumor necrosis factor‐α hemagglutinating virus of Japan Japan Reference Unit 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide
  21 in total

1.  Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure.

Authors:  T H Corbett; D P Griswold; B J Roberts; J C Peckham; F M Schabel
Journal:  Cancer Res       Date:  1975-09       Impact factor: 12.701

2.  [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].

Authors:  K Nakata; H Yoshida; S Kashimoto; Y Sohmura; S Nakamura; T Taguchi
Journal:  Gan To Kagaku Ryoho       Date:  1986-10

3.  Antitumor effects of natural-human TNF on BDF1 mice bearing lewis lung carcinoma.

Authors:  S Itano; S Fuchimoto; K Orita
Journal:  Hiroshima J Med Sci       Date:  1987-03

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Role of NK cells in the antimetastatic effect of anticoagulant drugs.

Authors:  E Gorelik; W W Bere; R B Herberman
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

6.  Simultaneous production of natural human tumor necrosis factor-alpha, -beta and interferon-alpha from BALL-1 cells stimulated by HVJ.

Authors:  S Fukuda; S Ando; O Sanou; M Taniai; M Fujii; N Masaki; K Nakamura; O Ando; K Torigoe; T Sugimoto
Journal:  Lymphokine Res       Date:  1988

7.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

8.  Novel experimental models of human cancer metastasis in nude mice: lung metastasis, intraabdominal carcinomatosis with ascites, and liver metastasis.

Authors:  Y Naomoto; H Kondo; N Tanaka; K Orita
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

9.  Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.

Authors:  R H Wiltrout; R B Herberman; S R Zhang; M A Chirigos; J R Ortaldo; K M Green; J E Talmadge
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

10.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; W Fiers; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

View more
  4 in total

1.  Electrochemotherapy significantly inhibits the growth of colon 26 tumors in mice.

Authors:  T Tada; K Matsumoto; H Suzuki
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  A YIGSR-containing novel mutein without the detrimental effect of human TNF-alpha of enhancing experimental pulmonary metastasis.

Authors:  K Miyata; M Kato; H Shikama; K Nishimura; N Sakae; K Kawagoe; T Nishikawa; K Kuroda; K Yamaguchi; Y Aoyama
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

3.  Antiproliferative effects of natural human tumor necrosis factor-alpha, interferon-alpha, and interferon-gamma on human pancreatic carcinoma cell lines.

Authors:  N Matsubara; S Fuchimoto; K Orita
Journal:  Int J Pancreatol       Date:  1991-04

4.  Antitumor effect of recombinant human interleukin-1 beta alone and in combination with natural human tumor necrosis factor-alpha.

Authors:  M Ohkura; S Fuchimoto; K Orita
Journal:  Jpn J Cancer Res       Date:  1990-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.